Estimate the FN and BMI Levels in Pregnant Women with Pre-Eclampsia

Preeclampsia, previously known as toxemia, impacts an estimated 4 million people globally and causes the deaths of over 70,000 mothers and 500,000 infants annually. Among all pregnancies, approximately 0.5% are affected by preterm pre-eclampsia, which accounts for 10% of pre-eclampsia cases. Preterm pre-eclampsia is more severe than pregnancies carried to term and linked to increased rates of mother and infant morbidity and death. In this investigation, 100 participants in total were divided into two groups: 50 pregnant women with pre-eclampsia and 50 pregnant women without pre-eclampsia in the control group. The severity of the condition was evaluated by analyzing biomarker FN with BMI of pregnant women. Microsoft Excel 2019 and SPSS software were used to assess the data gathered from August 2024 to December 2025. serum FN level and BMI were increase in patient group compared to the control. Serum FN level is a useful marker to predict and diagnose pre-eclampsia.